Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Regulatory News

Date Source Headline
1st Mar 2023 7:00 am RNS Incorporation of Inaphaea BioLabs Limited
24th Feb 2023 4:40 pm RNS Second Price Monitoring Extn
24th Feb 2023 4:35 pm RNS Price Monitoring Extension
2nd Feb 2023 12:45 pm RNS Result of GM, Issue of Equity
31st Jan 2023 7:02 am RNS Operational Update
31st Jan 2023 7:00 am RNS Holding(s) in Company
17th Jan 2023 4:36 pm RNS Broker Offer Results
17th Jan 2023 9:22 am RNS Posting of Circular and Notice of General Meeting
13th Jan 2023 7:01 am RNS Launch of Broker Offer
13th Jan 2023 7:00 am RNS Issue of Equity & Proposed Broker Offer
14th Dec 2022 5:01 pm RNS Holding(s) in Company
7th Dec 2022 1:06 pm RNS Holding(s) in Company
6th Dec 2022 4:40 pm RNS Second Price Monitoring Extn
6th Dec 2022 4:35 pm RNS Price Monitoring Extension
6th Dec 2022 12:00 pm RNS Shareholder Communications and Investor Webinar
6th Dec 2022 7:00 am RNS Quarterly Operational and Strategy Update
24th Oct 2022 7:00 am RNS Subsidiary Launched and IP License Signed
18th Oct 2022 7:00 am RNS Issue of Share Options
11th Oct 2022 7:00 am RNS Director Appointment
30th Sep 2022 8:47 am RNS Holding(s) in Company
22nd Sep 2022 7:00 am RNS Live Shareholder Q&A and industry events
8th Sep 2022 7:00 am RNS Appointment of Interim Chief Scientific Officer
6th Sep 2022 7:15 am RNS Proposed Appointment of Non-Executive Director
6th Sep 2022 7:00 am RNS Issue of Share Options
31st Aug 2022 7:00 am RNS Half-year Report
17th Aug 2022 7:00 am RNS Shareholder Communications
14th Jul 2022 10:46 am RNS Holding(s) in Company
13th Jul 2022 2:15 pm RNS Successful evaluation of breast cancer programme
7th Jul 2022 11:07 am RNS Director/PDMR Shareholding
5th Jul 2022 11:45 am RNS Holding(s) in Company
5th Jul 2022 7:00 am RNS Broker Option Results
30th Jun 2022 3:00 pm RNS Result of AGM and Appointment of Joint Broker
30th Jun 2022 10:31 am RNS Issue of Equity
30th Jun 2022 10:30 am RNS Extends exclusivity period for TheoremRx
17th Jun 2022 10:01 am RNS Update on VAL201 sub-license agreement
7th Jun 2022 4:33 pm RNS Annual Report, AGM Notice & Director Resignation
23rd Mar 2022 7:00 am RNS Update on proposed sub-license of VAL201
15th Mar 2022 7:00 am RNS Operational and Strategy Update
14th Feb 2022 7:00 am RNS Evaluation agreement with University of Barcelona
5th Jan 2022 4:41 pm RNS Second Price Monitoring Extn
FTSE 100 Latest
Value8,592.99
Change-41.81